1150618-23-7 Usage
Uses
Used in Organic Synthesis:
1-(3-bromoquinolin-6-yl)ethanone is used as a synthetic intermediate for the production of various complex organic chemicals. Its unique structure and functional groups make it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(3-bromoquinolin-6-yl)ethanone is used as a research compound for the development of new drugs. Its quinoline ring system and bromine substitution can be exploited to design and synthesize novel drug candidates with potential therapeutic applications.
Used in Chemical Analysis:
1-(3-bromoquinolin-6-yl)ethanone can be employed as a reference compound in chemical analysis and testing. Its well-defined structure and properties make it suitable for calibration of analytical instruments and validation of testing methods.
Used in Material Science:
In the field of material science, 1-(3-bromoquinolin-6-yl)ethanone may be used as a component in the development of new materials with specific properties. Its chemical structure can contribute to the formation of novel materials with applications in various industries, such as electronics, coatings, and plastics.
Check Digit Verification of cas no
The CAS Registry Mumber 1150618-23-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,0,6,1 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1150618-23:
(9*1)+(8*1)+(7*5)+(6*0)+(5*6)+(4*1)+(3*8)+(2*2)+(1*3)=117
117 % 10 = 7
So 1150618-23-7 is a valid CAS Registry Number.
1150618-23-7Relevant articles and documents
MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES
-
, (2017/08/01)
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES
-
, (2014/01/08)
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
